ArticleJournal of cancer research and clinical oncology2009

Cetuximab enhances the efficacy of bortezomib in squamous cell carcinoma cell lines.

Jens Wagenblast et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.